ERBB2 and triple-negative breast carcinoma: Indeed, SETD3 protein expression was markedly increased in both estrogen receptor (ER) positive and triple-negative breast cancer (TNBC) cells relative to normal breast epithelial MCF10A cells and human epidermal growth factor receptor 2 (HER2) positive SKBR3 cells (Fig. S1A).